These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12711804)

  • 41. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of smallpox vaccines using variola neutralization.
    Damon IK; Davidson WB; Hughes CM; Olson VA; Smith SK; Holman RC; Frey SE; Newman F; Belshe RB; Yan L; Karem K
    J Gen Virol; 2009 Aug; 90(Pt 8):1962-1966. PubMed ID: 19339477
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Newer smallpox vaccines require new test methods.
    Traynor K
    Am J Health Syst Pharm; 2011 Nov; 68(21):2012, 2014. PubMed ID: 22011978
    [No Abstract]   [Full Text] [Related]  

  • 44. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should remaining stockpiles of smallpox virus (variola) be destroyed?
    Weinstein RS
    Emerg Infect Dis; 2011 Apr; 17(4):681-3. PubMed ID: 21470459
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels.
    Rock MT; Yoder SM; Talbot TR; Edwards KM; Crowe JE
    J Infect Dis; 2004 Apr; 189(8):1401-10. PubMed ID: 15073677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In silico-accelerated identification of conserved and immunogenic variola/vaccinia T-cell epitopes.
    Moise L; McMurry JA; Buus S; Frey S; Martin WD; De Groot AS
    Vaccine; 2009 Oct; 27(46):6471-9. PubMed ID: 19559119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary vaccination against smallpox after preliminary vaccination with the attenuated vaccinia virus strain MVA and the use of a new "vaccination stamp"].
    Stickl H; Hochstein-Mintzel V; Huber HC
    Munch Med Wochenschr; 1973 Aug; 115(35):1471-3. PubMed ID: 4740817
    [No Abstract]   [Full Text] [Related]  

  • 49. Smallpox Vaccination of Laboratory Workers at US Variola Testing Sites.
    Medcalf S; Bilek L; Hartman T; Iwen PC; Leuschen P; Miller H; O'Keefe A; Sayles H; Smith PW
    Emerg Infect Dis; 2015 Aug; 21(8):1437-9. PubMed ID: 26196153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Epidemiological control of smallpox virus in Ecudor].
    Gutierrez Vera E
    Rev Ecuat Hig Med Trop; 1976; 29():13-24. PubMed ID: 189361
    [No Abstract]   [Full Text] [Related]  

  • 51. Revaccination studies in children with graded potency of smallpox vaccines.
    Pattanayak S; Sehgal CL; Choudhury S; Vijayan P
    Indian J Med Res; 1977 Jun; 65(6):756-9. PubMed ID: 203527
    [No Abstract]   [Full Text] [Related]  

  • 52. Smallpox and bioterrorism.
    Drazen JM
    N Engl J Med; 2002 Apr; 346(17):1262-3. PubMed ID: 11923485
    [No Abstract]   [Full Text] [Related]  

  • 53. Short- and long-term immunogenicity and protection induced by non-replicating smallpox vaccine candidates in mice and comparison with the traditional 1st generation vaccine.
    Ferrier-Rembert A; Drillien R; Tournier JN; Garin D; Crance JM
    Vaccine; 2008 Mar; 26(14):1794-804. PubMed ID: 18336966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Comparison of protective properties of the smallpox DNA-vaccine based on the variola virus A30L gene and its variant with modified codon usage].
    Maksiutov RA; Shchelkunov SN
    Mol Gen Mikrobiol Virusol; 2011; (2):30-4. PubMed ID: 21786633
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Persistence of cell-mediated immunity to vaccinia virus.
    Kim SH; Oh MD
    J Infect Dis; 2007 Sep; 196(5):805-6. PubMed ID: 17674329
    [No Abstract]   [Full Text] [Related]  

  • 56. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
    Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
    Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid spreading and immune evasion by vaccinia virus.
    Smith GL
    Adv Exp Med Biol; 2014; 808():65-76. PubMed ID: 24595611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
    Earl PL; Americo JL; Wyatt LS; Espenshade O; Bassler J; Gong K; Lin S; Peters E; Rhodes L; Spano YE; Silvera PM; Moss B
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10889-94. PubMed ID: 18678911
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The comparative study of the safety of a vaccinal process in both oral and epicutaneous immunization against smallpox].
    Bektimirov TA; Podkuĭko VN; Grigor'eva LV; Perekrest VV; Mikhaĭlov VV; Tereshkina NV; Dorokhina TV
    Vopr Virusol; 2002; 47(4):9-13. PubMed ID: 12271729
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smallpox and live-virus vaccination in transplant recipients.
    Fishman JA
    Am J Transplant; 2003 Jul; 3(7):786-93. PubMed ID: 12814470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.